The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Abstract
Anti-CD47 antibody is effective for treating malignant pediatric brain tumors without detectable toxicity in patient-derived xenograft models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Direct isolation of human central nervous system stem cells
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., Gage, F. H., & Weissman, I. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14720 · Cited by 1,849
Self-citationMajeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Self-citationWillingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,666
Self-citationCD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
Self-citationGardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Medulloblastoma Comprises Four Distinct Molecular Variants
Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., Bouffet, E., Clifford, S. C., Hawkins, C. E., French, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4324 · Cited by 1,339
Self-citationKool, M., Korshunov, A., Remke, M., Jones, D. T. W., Schlanstein, M., Northcott, P. A., Cho, Y.-J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,056
Self-citationIntegrin-associated protein (CD47) and its ligands
Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 878
Barclay, A. N., & van den Berg, T. K. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120142 · Cited by 841
CNS immune privilege: hiding in plain sight
Carson, M. J., Doose, J. M., Melchior, B., Schmid, C. D., & Ploix, C. C. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00441.x · Cited by 795
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776
Self-citationCD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Liu, X., Pu, Y., Cron, K., Deng, L., Kline, J., Frazier, W. A., Xu, H., Peng, H., Fu, Y.-X., & Xu, M. M. (2015) · Nature Medicine · doi:10.1038/nm.3931 · Cited by 767
Cho, Y.-J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., Berhoukim, R., Amani, V., Goumnerova, L., Eberhart, C. G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5148 · Cited by 717
Self-citationTseng, D., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Fathman, J. W., Fernhoff, N. B., Seita, J., Inlay, M. A., Weiskopf, K., Miyanishi, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305569110 · Cited by 657
Self-citationThe CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications
Chao, M. P., Weissman, I. L., & Majeti, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.01.010 · Cited by 649
Self-citationLigon, K. L., Huillard, E., Mehta, S., Kesari, S., Liu, H., Alberta, J. A., Bachoo, R. M., Kane, M., Louis, D. N., DePinho, R. A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.009 · Cited by 501
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Weiskopf, K., Ring, A. M., Ho, C. C. M., Volkmer, J.-P., Levin, A. M., Volkmer, A. K., Özkan, E., Fernhoff, N. B., van de Rijn, M., Weissman, I. L., et al. (2013) · Science · doi:10.1126/science.1238856 · Cited by 495
Self-citationPre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
Liu, J., Wang, L., Zhao, F., Tseng, S., Narayanan, C., Shura, L., Willingham, S., Howard, M., Prohaska, S., Volkmer, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137345 · Cited by 475
Self-citationThe Oligodendroglial Lineage Marker OLIG2 Is Universally Expressed in Diffuse Gliomas
Ligon, K. L., Alberta, J. A., Kho, A. T., Weiss, J., Kwaan, M. R., Nutt, C. L., Louis, D. N., Stiles, C. D., & Rowitch, D. H. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.499 · Cited by 438
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Ramaswamy, V., Remke, M., Bouffet, E., Faria, C. C., Perreault, S., Cho, Y.-J., Shih, D. J., Luu, B., Dubuc, A. M., Northcott, P. A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70449-2 · Cited by 394
Self-citationTherapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia
Chao, M. P., Alizadeh, A. A., Tang, C., Jan, M., Weissman-Tsukamoto, R., Zhao, F., Park, C. Y., Weissman, I. L., & Majeti, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2238 · Cited by 382
Self-citationIdentification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma
Read, T.-A., Fogarty, M. P., Markant, S. L., McLendon, R. E., Wei, Z., Ellison, D. W., Febbo, P. G., & Wechsler-Reya, R. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.016 · Cited by 370
BET Bromodomain Inhibition of MYC -Amplified Medulloblastoma
Bandopadhayay, P., Bergthold, G., Nguyen, B., Schubert, S., Gholamin, S., Tang, Y., Bolin, S., Schumacher, S. E., Zeid, R., Masoud, S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2281 · Cited by 352
Self-citationHedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., Masek, M., Attema, J. L., Li, G., Haddix, T., Edwards, M. S. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101657108 · Cited by 348
Self-citationGene expression analyses reveal molecular relationships among 20 regions of the human CNS
Roth, R. B., Hevezi, P., Lee, J., Willhite, D., Lechner, S. M., Foster, A. C., & Zlotnik, A. (2006) · Neurogenetics · doi:10.1007/s10048-006-0032-6 · Cited by 342
Cohen, K. J., Heideman, R. L., Zhou, T., Holmes, E. J., Lavey, R. S., Bouffet, E., & Pollack, I. F. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq205 · Cited by 331
The clinical implications of medulloblastoma subgroups
Northcott, P. A., Korshunov, A., Pfister, S. M., & Taylor, M. D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.78 · Cited by 328
Self-citationBlood–brain barrier breakdown in septic encephalopathy and brain tumours*
Davies, D. C. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00065.x · Cited by 309
Beckman, R. A., Weiner, L. M., & Davis, H. M. (2007) · Cancer · doi:10.1002/cncr.22402 · Cited by 281
Edris, B., Weiskopf, K., Volkmer, A. K., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Liu, J., Majeti, R., West, R. B., Fletcher, J. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121629109 · Cited by 258
Self-citationAnti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
Kim, D., Wang, J., Willingham, S. B., Martin, R., Wernig, G., & Weissman, I. L. (2012) · Leukemia · doi:10.1038/leu.2012.141 · Cited by 249
Self-citationEngraftment of sorted/expanded human central nervous system stem cells from fetal brain
Tamaki, S., Eckert, K., He, D., Sutton, R., Doshe, M., Jain, G., Tushinski, R., Reitsma, M., Harris, B., Tsukamoto, A., et al. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10412 · Cited by 241
Self-citationRecognition ligands on apoptotic cells: a perspective
Gardai, S. J., Bratton, D. L., Ogden, C. A., & Henson, P. M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005550 · Cited by 234
Studies on the chemotherapy of experimental brain tumors: development of an experimental model.
Ausman, J. I., Shapiro, W. R., & Rall, D. P. (1970) · PubMed · Cited by 223
Chao, M. P., Tang, C., Pachynski, R. K., Chin, R., Majeti, R., & Weissman, I. L. (2011) · Blood · doi:10.1182/blood-2011-02-338020 · Cited by 194
Self-citationMultipotent CD15+ Cancer Stem Cells in Patched-1 –Deficient Mouse Medulloblastoma
Ward, R. J., Lee, L., Graham, K., Satkunendran, T., Yoshikawa, K., Ling, E., Harper, L., Austin, R., Nieuwenhuis, E., Clarke, I. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0342 · Cited by 182
Radiation effects on cerebral white matter: MR evaluation
Tsuruda, J., Kortman, K., Bradley, W., Wheeler, D., Van Dalsem, W., & Bradley, T. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.1.165 · Cited by 178
Developing Interventions for Cancer-Related Cognitive Dysfunction in Childhood Cancer Survivors
Castellino, S. M., Ullrich, N. J., Whelen, M. J., & Lange, B. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju186 · Cited by 175
Mice Defective in Two Apoptosis Pathways in the Myeloid Lineage Develop Acute Myeloblastic Leukemia
Traver, D., Akashi, K., Weissman, I. L., & Lagasse, E. (1998) · Immunity · doi:10.1016/s1074-7613(00)80587-7 · Cited by 173
Self-citationNeurocognitive late effects in pediatric cancer
Mulhern, R. K., & Palmer, S. L. (2003) · Current Problems in Cancer · doi:10.1016/s0147-0272(03)00026-6 · Cited by 171
A prognostic gene expression signature in infratentorial ependymoma
For the Collaborative Ependymoma Research Network, Wani, K., Armstrong, T. S., Vera-Bolanos, E., Raghunathan, A., Ellison, D., Gilbertson, R., Vaillant, B., Goldman, S., Packer, R. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0941-4 · Cited by 162
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias
Jaiswal, S., Traver, D., Miyamoto, T., Akashi, K., Lagasse, E., & Weissman, I. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633833100 · Cited by 161
Self-citationMonoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier
Lampson, L. A. (2011) · mAbs · doi:10.4161/mabs.3.2.14239 · Cited by 152
O’Flaherty, J. D., Barr, M. P., Fennell, D. A., Richard, D. J., Reynolds, J. V., O’Leary, J. J., & O'Byrne, K. J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826bfbc6 · Cited by 148
Childhood brain tumors: epidemiology, current management and future directions
Pollack, I. F., & Jakacki, R. I. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.110 · Cited by 137
Klein, R. S., Izikson, L., Means, T. K., Gibson, H. D., Lin, E., Sobel, R. A., Weiner, H. L., & Luster, A. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.550 · Cited by 135
Epigenetics of cancer stem cells: Pathways and therapeutics
Shukla, S., & Meeran, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.09.017 · Cited by 135
Pollack, I. F. (2011) · Journal of Neurosurgery Pediatrics · doi:10.3171/2011.5.peds1178 · Cited by 120
Hoffman, L. M., Donson, A. M., Nakachi, I., Griesinger, A. M., Birks, D. K., Amani, V. M., Hemenway, M. S., Liu, A. K., Wang, M., Hankinson, T. C., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1212-8 · Cited by 87
Miller, S., Rogers, H. A., Lyon, P. C., Rand, V., Adamowicz‐Brice, M., Clifford, S. C., Hayden, J. T., Dyer, S., Pfister, S. M., Korshunov, A., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor070 · Cited by 79
Topical Review Article: Brainstem Glioma: I. Pathology, Clinical Features, and Therapy
Maria, B. L., Rehder, K., Eskin, T. A., Hamed, L. M., Fennell, E. B., Quisling, R. G., Mickle, J. P., Marcus, R. B., Drane, W. E., Mendenhall, N. P., et al. (1993) · Journal of Child Neurology · doi:10.1177/088307389300800203 · Cited by 78
Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma
Donson, A. M., Birks, D. K., Barton, V. N., Wei, Q., Kleinschmidt-DeMasters, B. K., Handler, M. H., Waziri, A. E., Wang, M., & Foreman, N. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902811 · Cited by 63
Knipstein, J. A., Birks, D. K., Donson, A. M., Alimova, I., Foreman, N. K., & Vibhakar, R. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor208 · Cited by 60
Immunotherapy for malignant glioma
Suryadevara, C. M., Sanchez-Perez, L. A., Sampson, J. H., Verla, T. G., Reap, E. A., Choi, B., & Fecci, P. E. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.151341 · Cited by 42
Neurological complications following treatment of children with brain tumors
Monje, M., & Fisher, P. G. (2011) · Journal of Pediatric Rehabilitation Medicine · doi:10.3233/prm-2011-0150 · Cited by 27
Self-citation
Cited by
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
Advani, R., Flinn, I., Popplewell, L., Forero, A., Bartlett, N. L., Ghosh, N., Kline, J., Roschewski, M., LaCasce, A., Collins, G. P., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1807315 · Cited by 1,126
Self-citationTargeting tumor-associated macrophages in cancer
Pathria, P., Louis, T. L., & Varner, J. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.003 · Cited by 933
Metadata
- Authors
- Gholamin, S., Mitra, S. S., Feroze, A. H., Liu, J., Kahn, S. A., Zhang, M., Esparza, R., Richard, C., Ramaswamy, V., Remke, M., Volkmer, A. K., Willingham, S., Ponnuswami, A., McCarty, A., Lovelace, P., Storm, T. A., Schubert, S., Hutter, G., Narayanan, C., Chu, P., Raabe, E. H., Harsh, G., Taylor, M. D., Monje, M., Cho, Y.-J., Majeti, R., Volkmer, J. P., Fisher, P. G., Grant, G., Steinberg, G. K., Vogel, H., Edwards, M., Weissman, I. L., & Cheshier, S. H.
- Venue
- Science Translational Medicine
- Published
- 2017-03-15
- Volume
- 9
- Issue
- 381
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2597064996
- Cited by
- 426
- References
- 55
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.